ICAD 1.54 (+0%)
US44934S2068Healthcare Providers & ServicesHealth Information Services

Icad (ICAD) Stock Highlights

1.54 | +0%
2024-11-23 06:19:10
icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers.

Statistics

Range Today
1.51 1.59
Volume Today 171.2K
Range 1 Year
1.18 2.65
Volume 1 Year 45.17M
Range 3 Year
1.05 8.57
Volume 3 Year 212.28M
Range 10 Year
1.05 21.44
Volume 10 Year 412.36M

Highlights

Market Capitalization 56.13M (small)
Floating Shares 24.82M
Current Price 1.54
Price To Earnings -10.67
Price To Revenue 1.93
Price To Book 1.81
Earnings Per Share -0.18
Payout Ratio 0%

Performance

Latest 0%
1 Month -14.44%
3 Months -10.98%
6 Months -5.52%
1 Year +17.56%
3 Years -82.03%
5 Years -77.71%
10 Years -85.09%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.